Obermatt

USANA Health Sciences

NYQ:USNA · US90328M1071
Personal ProductsMedium

360

96
EV / EBIT92
Price / Owner Earnings47
Owner Earnings Yield90
Dividend Yield1
Price/Sales95
EV / Gross Profit97
Price/Book82
Return on Capital53
Cash Return on Capital42
Return on Equity28
EBIT Margin28
Gross Profitability95
Cash Conversion79
Accruals47
Owner Earnings Margin35
Sales growth28
Profit Growth56
Long-Term EPS Growth75
Owner Earnings Growth27
Reinvestment51
Price momentum24
Debt load89
Refinancing80
Debt Payback100
Liquidity92
Analyst ratings1
Opinion Changes1
Price Target Upside92
Market mood26
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

USANA Health Sciences clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryPersonal Products
SizeMedium
TypePublic Company
ExchangeNYSE
Founded1992
Employees5,902
Websiteusana.com
ISINUS90328M1071
Last UpdateApr 2, 2026
Index & Theme
CardiovascularWellness and RecoveryLifestyleNutraceuticalBiotechnologyDietary SupplementsDirect SalesFitnessHealth CareNutritionWellness

Description

USANA Health Sciences, Inc. (USANA) develops and manufactures nutritional supplements, functional foods and personal care products that are sold throughout the world. The company is committed to continuous product innovation and sound scientific res…

Analysis

Bargain bin

USANA Health Sciences, Inc. is priced cheaply, and that invites the natural question of why, since the underlying business scores below average.

On valuation, the picture is attractive. The owner-earnings multiple stands at 13.2×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 1% a year, against analyst forecasts of 12%. The price, in other words, assumes less than the experts do.

Growth is moderate; the safety picture is sturdy. The company scores 8/20 on our value-creation score: creating some value. Analysts lean positive.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
63
2023202420252026

All-time high

71

Mar 2026

All-time low

39

Jan 2023

Average rank

61

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
95
85
73
70
Price/Earnings
62
63
34
61
Price/Book
82
53
43
14
Dividend Yield
1
1
1
1
Value (overall)
85
70
39
41

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare USANA Health Sciences with its peers
Nu Skin
NYQ:NUS
78
CountryUSA
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
FitLife Brands
NAQ:FTLF
38
CountryUSA
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Nature's Sunshine
NAQ:NATR
94
CountryUSA
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
Medifast
NYQ:MED
20
CountryUSA
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Bioharvest Sciences
MUN:8MV0
19
CountryCanada
IndustryPersonal Products
SizeSmall
Full Stock Analysis →
Jamieson Wellness
TOR:JWEL
38
CountryCanada
IndustryPersonal Products
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →